Aligos Therapeutics (ALGS) Current Deferred Revenue (2020 - 2025)
Aligos Therapeutics (ALGS) posted Current Deferred Revenue of $168,000 for Q3 2025, down 71.0% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Aligos Therapeutics' Current Deferred Revenue came in at $151,000, down 88.5% from FY2023.
- Annual Current Deferred Revenue shows a four-year compound annual growth rate of -62.8% (FY2020 to FY2024).
- In prior years, Aligos Therapeutics' Current Deferred Revenue was $1.31 million in FY2023 (-85.0%), $8.74 million in FY2022 (+14.4%), $7.64 million in FY2021 (-3.2%) and $7.89 million in FY2020.
- Quarterly Current Deferred Revenue has run from a low of $151,000 in Q4 2024 to a high of $15.07 million in Q1 2022 over five years.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q1 2022, with growth of 98.7%; the weakest was Q4 2024, with a decline of 88.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Aligos Therapeutics | 53.51 Mn | -274.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 579,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 8.74 Mn |
| Sep 30, 2022 | 10.73 Mn |
| Jun 30, 2022 | 13.13 Mn |
| Mar 31, 2022 | 15.07 Mn |
| Dec 31, 2021 | 7.64 Mn |
| Sep 30, 2021 | 6.64 Mn |
| Jun 30, 2021 | 6.81 Mn |
| Mar 31, 2021 | 7.58 Mn |
| Dec 31, 2020 | 7.89 Mn |
API Access
Aligos Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();